| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 30.82B | 30.80B | 29.33B | 32.22B | 27.80B | 22.95B |
| Gross Profit | 7.35B | 7.26B | 6.29B | 7.61B | 5.78B | 5.28B |
| EBITDA | 3.88B | 3.75B | 3.18B | 4.57B | 3.33B | 2.85B |
| Net Income | 2.25B | 2.03B | 1.44B | 2.96B | 1.50B | 1.08B |
Balance Sheet | ||||||
| Total Assets | 52.20B | 47.11B | 47.03B | 45.00B | 41.57B | 37.18B |
| Cash, Cash Equivalents and Short-Term Investments | 15.55B | 13.94B | 12.69B | 9.32B | 8.78B | 8.50B |
| Total Debt | 5.65B | 3.08B | 3.35B | 3.31B | 4.56B | 4.37B |
| Total Liabilities | 12.22B | 8.38B | 9.54B | 10.86B | 11.15B | 9.70B |
| Stockholders Equity | 38.82B | 38.72B | 37.48B | 34.13B | 30.42B | 27.48B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 2.28B | 3.12B | -273.00M | -118.00M | -1.14B |
| Operating Cash Flow | 0.00 | 3.89B | 4.20B | 1.60B | 968.00M | 1.32B |
| Investing Cash Flow | 0.00 | -2.24B | -1.35B | -677.00M | -284.00M | -3.02B |
| Financing Cash Flow | 0.00 | -912.00M | -763.00M | -1.68B | -305.00M | -306.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
87 Outperform | ¥43.58B | 16.86 | ― | 3.48% | 18.42% | 51.06% | |
78 Outperform | ¥177.72B | 12.04 | 8.27% | 2.68% | -2.45% | 7.31% | |
74 Outperform | ¥62.39B | 9.41 | ― | 1.52% | 5.75% | 59.69% | |
73 Outperform | ¥239.06B | 9.23 | ― | 3.90% | 2.65% | 7.16% | |
68 Neutral | ¥103.48B | 9.91 | ― | 2.91% | 31.48% | 83.15% | |
65 Neutral | ¥239.18B | 14.72 | 8.35% | 2.73% | 3.35% | 810.44% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |